Amplifon (AMP) M&A announcement summary
Event summary combining transcript, slides, and related documents.
M&A announcement summary
17 Mar, 2026Deal rationale and strategic fit
Creates a global, vertically integrated leader in audiology and hearing care, combining advanced product innovation, clinical expertise, and patient insights to elevate industry standards worldwide.
Addresses growing global demand for advanced hearing solutions, leveraging demographic trends, technological progress, and complementary strengths.
Unlocks untapped growth potential through scale, innovation, and expanded market reach, especially in the U.S. and Europe.
GN Hearing brings leading technology, operational expertise, and a strong commercial platform; Amplifon adds clinical know-how and a global retail network.
Preserves and enhances GN Hearing's brand identity and culture within the new group, supported by strong cultural alignment and complementary business models.
Financial terms and conditions
Total consideration is approximately €2.3 billion: €1.69 billion in cash and 56 million newly issued shares, valuing GN Hearing on a cash-free, debt-free basis.
Cash component is fully covered by a committed bridge facility, to be refinanced via debt and equity or equity-linked instruments.
Pro-forma net debt to adjusted EBITDA expected at around 3.0x at closing, reducing to below 2.9x with synergies.
GN Store Nord will hold a 16% stake in the new group and appoint a board member.
Both Boards and key shareholders have unanimously approved the deal and committed to participate in the equity raise.
Synergies and expected cost savings
Identified run-rate net EBITDA synergies of €60–80 million by 2029, mainly from volume insourcing.
One-off integration costs estimated at €80 million over two to three years post-closing.
Additional upside potential from manufacturing, procurement, working capital, CapEx optimization, and future revenue synergies.
Synergies are considered highly executable with limited delivery risk and clear implementation plans.
Integration costs and potential dis-synergies are factored into synergy estimates.
Latest events from Amplifon
- Revenue up 1.7% at constant FX; Fit4Growth drives margin gains amid market headwinds.AMP
Q4 20254 Mar 2026 - Strong H1 2024 growth and profitability, with robust M&A and global network expansion.AMP
Q2 20242 Feb 2026 - Revenue up 8% at constant FX to €1.74bn, net profit €104.2m, outlook for high single-digit growth.AMP
Q3 202417 Jan 2026 - 2024 saw 7% revenue growth and margin investment; 2025 targets 5–9% growth and higher profitability.AMP
Q4 202415 Dec 2025 - Q1 2025 delivered record EBITDA margin, 2.6% revenue growth, and guidance confirmation.AMP
Q1 202518 Nov 2025 - Q3 organic growth returned, but margins and profit fell; FY2025 targets modest gains.AMP
Q3 20256 Nov 2025 - Margins fell as revenue growth slowed, prompting a new margin improvement program.AMP
Q2 202530 Oct 2025